Sandia Biotech is proud to announce a strategic partnership with Confocal.nl, the Dutch Microscopy Company. Please join us as we combine our FluorAbody® technology with a game-changing confocal imaging platform that provides super-resolution capability with higher sensitivity than most confocal microscopes. Confocal.nl has advanced the art for super resolution and demonstrated low laser power (see confocal.nl challenge) that enables important biologically relevant applications using spheroids, organoids, and tumoroids. https://bright-i.nl/home-7/the-challenge/
Timelapse of approximately 1 hour of HUVECs stained for Actin-RFP (red), Mitochondria-GFP (green), and Nucleus-SiR DNA (magenta). Imaged with the Re-scan Confocal Microscope (RCM) on an Olympus IX83 with 1.5NA 100x TIRF objective. Laser power for GFP: 1 microwatt, RFP: 1 microwatt, SiR DNA: 3 microwatts. Sample Courtesy: Philippa Phelp, Amsterdam UMC, location VUmc, Amsterdam.
In It
To Change Lives
We’re driven by a singular mission — to make Sandia Biotech a leading cancer diagnostics and therapeutics company. Our core values are:
— Be impeccable with Your Word
— Don't Take Anything Personally
— Don't Make Assumptions
— Always Do Your Best
The success of any venture is anchored in one's absolute alignment to purpose. The entire TEAM at Sandia Biotech is committed to this mission and living these core values. Please join us.
Trastuzumab (Herceptin™) is a monoclonal antibody (huMAb4D5-8) that targets the Her2 receptor protein and is widely used in immunotherapy of breast cancer.
4D5-8 single-chain variable fragment (scFv) was used to construct the Anti-Her2-RFP FluorAbody.
Importance: 1:1 Ratio of binding site to Fluorescent Protein
- Better quantitation and reproducible reagent performance compared to fluorochrome-labeled antibodies
Human Breast Cancer Cell Line SK-BR-3; ErbB2 Staining with Anti-Her2 RFP FluorAbody®
SK-BR-3 cells were fixed with 4% paraformaldehyde containing DAPI and incubated with anti-Her2-mRFP. Nuclei are blue and ErbB2 (as detected by anti-Her2-RFP) is labeling the cellular membrane (red). Cells were imaged in epifluorescence with TRITC and DAPI filters and a 63x oil objective.
Formalin Fixed and Parafin-Embedded Tissue; Human ErbB2 Staining Shows High Her2 Positive Breast Cancer Tissue
Immunofluorescence staining and detection of Her2 (ErbB2) biomarker in formalin-fixed and parafin-embedded breast tissue from a Her2 positive tissue sample. This result clearly shows that the Anti-Her2 FluorAbody can be used as a diagnostic reagent in breast cancer tissue.
Triple Negative Epithelial Human Breast Cancer Cell Line MDAMB231 Labeled with Anti-EphA2-Cerlulean FluorAbody®
Immunofluorescence analysis of the anti-EphA2-cerulean biomarker. (A) Labeling of the EphA2 receptor with primary and secondary antibody fluorochrome labeled with AF488. (B) Labeling of EphA2 with the anti-EphA2-cerulean FluorAbody. The epithelial human breast cancer cell line, MDAMB231, was stimulated with dimeric ephrinA1-F. The AF488 labeled sample shows a more diffuse staining pattern when compared to the distinct punctate staining pattern shown using the anti-EphA2- cerulean FluorAbody. This result clearly shows that the FluorAbody reagent is superior and provides a more specific staining pattern with more biologically relevant imaging results.
Sandia Biotech Products
Anti-Her2 RFP FluorAbody
SuperFolder GFP Fluorescence in Thermophilus
N-terminus linked ferritin folds correctly and C-terminus folds poorly
Sandia Biotech Application Notes
